Results show no clinical benefit from use of hydroxychloroquine in COVID-19 patients
The RECOVERY trial has shown that hydroxychloroquine is not an effective treatment in patients hospitalized with COVID-19
The RECOVERY trial has shown that hydroxychloroquine is not an effective treatment in patients hospitalized with COVID-19
This aims to make use of its collective and accumulated knowledge of graphene to fight the current pandemic
Hybrid nanocapsules from renewable material hope to help cut carbon emissions
Deal enables a wider suite of pre-clinical testing services in oncology
New kits support analysis of all organs and species on fresh/fixed frozen and FFPE samples
The trial will study the use of ruxolitinib, a JAK inhibitor, to investigate its effect on reducing complications in deteriorating COVID-19 patients
A rare lung disease drug is being trialed to help fight COVID-19
Automated “lateral flow” dispensing technology is vital step in rapid point-of-care antibody test production
Olympus imaging systems empower next-generation cancer research at USC’s Ellison Institute
The study is expected to begin enrolling in June with a target of approximately 450 patients globally
Company to make the device available through broad range of healthcare, state, employer and consumer-initiated channels
The first 4,000 doses have been delivered for use in the Phase 2/3 clinical trial COV002 by the University of Oxford